Compare Cassava Sciences Inc (FLNA) vs Honeywell International Inc (HON) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Honeywell (HON) trades at $223.30, up 0.28% with neutral technical signals. Recent financials show a P/E of 17.8 and net income margin of 10.89%, though revenue dipped to $37.44B in 2025. The company completed a 2:1 reverse stock split on June 29, 2026, and maintains strong analyst support with a $368.55 consensus price target. Earnings have consistently beaten expectations, with Q2 2026 results pending.

Outlook is cautiously optimistic given HON's automation focus post-spinoffs, but near-term execution risks and margin pressures pose challenges. The stock offers value with upside potential if management delivers on growth targets, though investors should monitor segment performance and debt levels.